Annual Shareholders Equity
$128.81 M
-$87.92 M-40.57%
September 30, 2024
Summary
- As of February 8, 2025, ENTA annual stockholders equity is $128.81 million, with the most recent change of -$87.92 million (-40.57%) on September 30, 2024.
- During the last 3 years, ENTA annual shareholders equity has fallen by -$270.62 million (-67.75%).
- ENTA annual shareholders equity is now -72.15% below its all-time high of $462.49 million, reached on September 30, 2019.
Performance
ENTA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$128.81 M
-$20.10 M-13.50%
September 30, 2024
Summary
- As of February 8, 2025, ENTA quarterly stockholders equity is $128.81 million, with the most recent change of -$20.10 million (-13.50%) on September 30, 2024.
- Over the past year, ENTA quarterly shareholders equity has dropped by -$87.92 million (-40.57%).
- ENTA quarterly shareholders equity is now -73.49% below its all-time high of $485.99 million, reached on March 31, 2020.
Performance
ENTA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ENTA Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.6% | -40.6% |
| 3 y3 years | -67.8% | -67.8% |
| 5 y5 years | -72.2% | -67.8% |
ENTA Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -67.8% | at low | -66.5% | at low |
| 5 y | 5-year | -72.2% | at low | -73.5% | at low |
| alltime | all time | -72.2% | +486.8% | -73.5% | +216.8% |
Enanta Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $128.81 M(-40.6%) | $128.81 M(-13.5%) |
| Jun 2024 | - | $148.91 M(-10.4%) |
| Mar 2024 | - | $166.11 M(-13.4%) |
| Dec 2023 | - | $191.88 M(-11.5%) |
| Sep 2023 | $216.74 M(-32.6%) | $216.74 M(-8.9%) |
| Jun 2023 | - | $237.82 M(-11.7%) |
| Mar 2023 | - | $269.38 M(-10.5%) |
| Dec 2022 | - | $300.84 M(-6.4%) |
| Sep 2022 | $321.33 M(-19.6%) | $321.33 M(-4.9%) |
| Jun 2022 | - | $338.02 M(-5.7%) |
| Mar 2022 | - | $358.58 M(-6.7%) |
| Dec 2021 | - | $384.38 M(-3.8%) |
| Sep 2021 | $399.43 M(-12.3%) | $399.43 M(-4.4%) |
| Jun 2021 | - | $417.85 M(-4.2%) |
| Mar 2021 | - | $436.03 M(-3.5%) |
| Dec 2020 | - | $452.00 M(-0.8%) |
| Sep 2020 | $455.58 M(-1.5%) | $455.58 M(-5.2%) |
| Jun 2020 | - | $480.56 M(-1.1%) |
| Mar 2020 | - | $485.99 M(+0.8%) |
| Dec 2019 | - | $482.29 M(+4.3%) |
| Sep 2019 | $462.49 M(+17.5%) | $462.49 M(+3.2%) |
| Jun 2019 | - | $448.10 M(+2.7%) |
| Mar 2019 | - | $436.21 M(+2.2%) |
| Dec 2018 | - | $426.83 M(+8.4%) |
| Sep 2018 | $393.68 M | $393.68 M(+9.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $360.90 M(+8.2%) |
| Mar 2018 | - | $333.40 M(+5.0%) |
| Dec 2017 | - | $317.58 M(+5.3%) |
| Sep 2017 | $301.68 M(+11.8%) | $301.68 M(+15.6%) |
| Jun 2017 | - | $260.87 M(-1.9%) |
| Mar 2017 | - | $266.01 M(-0.8%) |
| Dec 2016 | - | $268.17 M(-0.7%) |
| Sep 2016 | $269.94 M(+14.3%) | $269.94 M(+0.3%) |
| Jun 2016 | - | $269.01 M(+1.0%) |
| Mar 2016 | - | $266.42 M(+0.8%) |
| Dec 2015 | - | $264.28 M(+11.9%) |
| Sep 2015 | $236.16 M(+58.9%) | $236.16 M(+3.4%) |
| Jun 2015 | - | $228.28 M(+1.8%) |
| Mar 2015 | - | $224.22 M(+15.7%) |
| Dec 2014 | - | $193.71 M(+30.3%) |
| Sep 2014 | $148.65 M(+34.6%) | $148.65 M(-2.8%) |
| Jun 2014 | - | $152.95 M(+50.4%) |
| Mar 2014 | - | $101.72 M(-3.7%) |
| Dec 2013 | - | $105.58 M(-4.4%) |
| Sep 2013 | $110.47 M(+151.5%) | $110.47 M(-3.4%) |
| Jun 2013 | - | $114.41 M(-3.3%) |
| Mar 2013 | - | $118.38 M(+78.8%) |
| Dec 2012 | - | $66.22 M(+50.7%) |
| Sep 2012 | $43.93 M(+100.1%) | $43.93 M(-139.8%) |
| Jun 2012 | - | -$110.25 M(-602.2%) |
| Sep 2011 | $21.95 M | $21.95 M |
FAQ
- What is Enanta Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals annual shareholders equity year-on-year change?
- What is Enanta Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Enanta Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of ENTA is $128.81 M
What is the all time high annual shareholders equity for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high annual stockholders equity is $462.49 M
What is Enanta Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, ENTA annual stockholders equity has changed by -$87.92 M (-40.57%)
What is Enanta Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of ENTA is $128.81 M
What is the all time high quarterly shareholders equity for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high quarterly stockholders equity is $485.99 M
What is Enanta Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, ENTA quarterly stockholders equity has changed by -$87.92 M (-40.57%)